No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15-Reference-Cited by-同舟云学术

No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15

Published:2013-10-26 Issue:3 Volume:164 Page:376-383
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Kato Motohiro¹²,Koh Katsuyoshi¹,Manabe Atsushi³,Saito Tomohiro⁴,Hasegawa Daisuke³,Isoyama Keiichi⁵,Kinoshita Akitoshi⁶,Maeda Miho⁷,Okimoto Yuri⁸,Kajiwara Michiko⁹,Kaneko Takashi¹⁰,Sugita Kanji¹¹,Kikuchi Akira¹²,Tsuchida Masahiro¹³,Ohara Akira¹⁴

Affiliation:

1. Department of Haematology/Oncology; Saitama Children's Medical Centre; Saitama Japan

2. Department of Paediatrics; the University of Tokyo; Tokyo Japan

3. Department of Paediatrics; St. Luke's International Hospital; Tokyo Japan

4. Department of Health Policy; National Research Institute for Child Health and Development; Tokyo Japan

5. Department of Paediatrics; Showa University Fujigaoka Hospital; Yokohama Japan

6. Department of Paediatrics; St. Marianna University School of Medicine; Kawasaki Japan

7. Department of Paediatrics; Nippon Medical School; Tokyo Japan

8. Department of Haematology/Oncology; Chiba Children's Hospital; Chiba Japan

9. Department of Paediatrics; Tokyo Medical and Dental University; Tokyo Japan

10. Department of Haematology/Oncology; Tokyo Metropolitan Children's Medical Centre; Tokyo Japan

11. Department of Paediatrics; University of Yamanashi; Yamanashi Japan

12. Department of Paediatrics; Teikyo University; Tokyo Japan

13. Department of Paediatrics; Ibaraki Children's Hospital; Ibaraki Japan

14. Department of Paediatrics; Toho University; Tokyo Japan

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12632/fullpdf

Reference30 articles.

1. Efficacy of high-dose methotrexate in childhood acute lymphocytic leukemia: analysis by contemporary risk classifications;Abromowitch;Blood,1988

2. Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II;Arico;Blood,2002

3. Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421;Becton;Blood,2006

4. Idarubicin and cytosine arabinoside reinduction therapy for children with multiple recurrent or refractory acute lymphoblastic leukemia: a Pediatric Oncology Group study;Bernstein;Journal of Pediatric Hematology/oncology,1997

5. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia;Boos;Medical and Pediatric Oncology,1996

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testicular involvement of acute lymphoblastic leukemia in children and adolescents: Diagnosis, biology, and management;Cancer;2021-05-25

2. Nationwide study of pediatric B‐cell precursor acute lymphoblastic leukemia with chromosome 8q24/ MYC rearrangement in Japan;Pediatric Blood & Cancer;2020-04-23

3. Nationwide survey of pediatric hypodiploid acute lymphoblastic leukemia in Japan;Pediatrics International;2019-11

4. Glucocorticoids attenuate the sensitivity of glucocorticoid-resistant lymphoid cells to doxorubicin via reduction in OCTN2;Molecular and Cellular Biochemistry;2019-05-16

5. The failure of radical treatments to cure cancer: can less deliver more?;Therapeutic Advances in Vaccines and Immunotherapy;2018-10